Anne Kallioniemi
YOU?
Author Swipe
View article: Supplementary Figure 1 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Figure 1 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 90K, The first row shows the amino acid sequence. In the second row the predicted secondary structure is illustrated with blue (coil), red (alpha-helix) and green (beta-strand) bars. In the third row numerical value for the conf…
View article: Supplementary Table 5 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 5 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 43K, Table shows 30 amino acids having the lowest relative solvent accessibilities. The first column indicates the predicted class for the amino acid denoted by the letters B (buried) and E (exposed). Second Column shows the ami…
View article: Supplementary Table 1 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 1 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 84K, Different sample types included in the analyses are presented in this file.
View article: Supplementary Table 2 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 2 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 47K, Presentation of segregation analysis.
View article: Data from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Data from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
Background: A recently identified germline mutation G84E in HOXB13 was shown to increase the risk of prostate cancer. In a family-based analysis by The International Consortium for Prostate Cancer Genetics (ICPCG), the G84E mutation was mo…
View article: Supplementary Table 2 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 2 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 47K, Presentation of segregation analysis.
View article: Supplementary Table 1 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 1 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 84K, Different sample types included in the analyses are presented in this file.
View article: Supplementary Figure 1 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Figure 1 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 90K, The first row shows the amino acid sequence. In the second row the predicted secondary structure is illustrated with blue (coil), red (alpha-helix) and green (beta-strand) bars. In the third row numerical value for the conf…
View article: Supplementary Table 5 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 5 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 43K, Table shows 30 amino acids having the lowest relative solvent accessibilities. The first column indicates the predicted class for the amino acid denoted by the letters B (buried) and E (exposed). Second Column shows the ami…
View article: Supplementary Table 4 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 4 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 39K, The first column indicates the predicted class for the amino acid denoted by the letters B (buried) and E (exposed). Second Column shows the amino acid while in third column the amino acid position is indicated. Fourth colu…
View article: Supplementary Table 3 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 3 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 38K, Table includes the results of six tolerance predictors and two protein stability predictors included in Pon-P selected for in silico analysis.
View article: Data from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Data from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
Background: A recently identified germline mutation G84E in HOXB13 was shown to increase the risk of prostate cancer. In a family-based analysis by The International Consortium for Prostate Cancer Genetics (ICPCG), the G84E mutation was mo…
View article: Supplementary Table 3 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 3 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 38K, Table includes the results of six tolerance predictors and two protein stability predictors included in Pon-P selected for in silico analysis.
View article: Supplementary Table 4 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Supplementary Table 4 from <i>HOXB13</i> G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk Open
PDF file - 39K, The first column indicates the predicted class for the amino acid denoted by the letters B (buried) and E (exposed). Second Column shows the amino acid while in third column the amino acid position is indicated. Fourth colu…
View article: Supplementary Table 5 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 5 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 5 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Supplementary Table 1 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 1 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 1 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Supplementary Table 2 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 2 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 2 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Supplementary Table 2 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 2 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 2 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Supplementary Table 4 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 4 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 4 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Supplementary Table 5 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 5 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 5 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Supplementary Table 3 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 3 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 3 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Data from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Data from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Pancreatic cancer is a highly aggressive disease characterized by poor prognosis and vast genetic instability. Recent microarray-based, genome-wide surveys have identified multiple recurrent copy number aberrations in pancreatic cancer; ho…
View article: Supplementary Table 3 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 3 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 3 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Data from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Data from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Pancreatic cancer is a highly aggressive disease characterized by poor prognosis and vast genetic instability. Recent microarray-based, genome-wide surveys have identified multiple recurrent copy number aberrations in pancreatic cancer; ho…
View article: Supplementary Table 4 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 4 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 4 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Supplementary Table 1 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Supplementary Table 1 from <i>Intersex-like</i> (<i>IXL</i>) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Open
Supplementary Table 1 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
View article: Novel ZNF414 activity characterized by integrative analysis of ChIP-exo, ATAC-seq and RNA-seq data
Novel ZNF414 activity characterized by integrative analysis of ChIP-exo, ATAC-seq and RNA-seq data Open
Transcription factor binding to DNA is a central mechanism regulating gene expression. Thus, thorough characterization of this process is essential for understanding cellular biology in both health and disease. We combined data from three …
View article: Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Ovarian Cancer Cells <i>In Vitro</i>
Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Ovarian Cancer Cells <i>In Vitro</i> Open
The results imply that combining 1,25-D3 with paclitaxel and carboplatin may potentiate their growth inhibitory effect on ovarian cancer cells with high VDR expression.